Science
New report describes positive results of generic drug in treating COVID – PRNewswire
/PRNewswire/ — The Covid Early Treatment Fund (CETF) www.treatearly.org announced today that the medical journal Open Forum Infectious Diseases published a…
BERKELEY, Calif., Feb. 1, 2021 /PRNewswire/ — The Covid Early Treatment Fund (CETF) www.treatearly.org announced today that the medical journal Open Forum Infectious Diseases published a report that outlines the success in using a generic drug fluvoxamine to prevent complications of COVID-19.
“This real-world evidence study provides additional independent confirmation that fluvoxamine is highly effective in preventing hospitalization and death from COVID,” said Steve Kirsch, a Silicon Valley…
-
General22 hours agoa pivotal moment in Liberal power struggle
-
Noosa News22 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General20 hours agoRussia launches its biggest attack on Ukraine’s gas network since war began on the eve of winter
-
Business19 hours agoAmazon will stage a major comeback in the next 3 years. Here’s 1 reason why.